In late May 2025, Kaylie Marie Bailey, a 36-year-old mother of three from County Durham, sought what she believed to be a routine cosmetic treatment to erase the frown lines on her forehead. Kaylie had previously undergone Botox injections with no complications, her last treatment being roughly 18 months earlier. This time, however, her experience turned into a nightmare that nearly cost her life.
Kaylie found a beautician offering Botox services through Facebook Messenger. The beautician invited her to a local hair salon in Blackhall Rocks, where the treatment was scheduled for May 30. Trusting the provider and hopeful for positive results, Kaylie agreed to injections targeting multiple areas of her face — the sides of her eyes, forehead, and the glabellar region, the area between the eyebrows often prone to deep wrinkles.
As the needle pierced her skin, Kaylie immediately felt an intense burning sensation accompanied by uncontrollable tearing. Although disturbed, she initially assumed this was a normal reaction to the injections. The beautician dismissed her concerns and, perhaps aware that the product used was substandard, offered to halve the cost of the session from £150 to £75. Unbeknownst to Kaylie, the toxin injected was a counterfeit, unsafe product that would soon trigger severe health consequences.

Within a few hours after the treatment, Kaylie began feeling unwell. Days passed and her symptoms worsened: she experienced dizziness and noticed her left eyelid drooping. One frightening Monday, while driving her 12-year-old son Olly to school, Kaylie suddenly observed two buses side-by-side on the road — double vision that she could not clear no matter how much she blinked. Fearful but overwhelmed by the demands of motherhood, she did not immediately seek medical attention.
As the week went on, family members noticed the increasing droop in Kaylie’s eyelid and urged her to see a doctor. On Friday, June 6, she visited a medical professional and was quickly referred to the Accident & Emergency department at a nearby hospital. Doctors performed a CT scan to rule out brain injury and administered morphine for pain relief. They diagnosed her with ptosis — a condition where the eyelid droops due to muscle weakness or nerve damage. The medical team reassured her that the condition would likely improve with time and discharged her.
Despite the diagnosis, Kaylie felt something more serious was wrong. However, her concerns were downplayed, and no further investigation was done at that time.
While Kaylie’s health deteriorated, a cluster of similar cases began to emerge across County Durham. Dozens of individuals reported alarming symptoms following botulinum toxin injections: drooping facial muscles, slurred speech, increasing double vision, difficulty swallowing, and general muscle weakness. Eleven of these patients required hospital admission due to suspected botulism, a rare but serious condition caused by the neurotoxin produced by Clostridium botulinum bacteria.
The UK Health Security Agency (UKHSA), local NHS Trusts, and Durham County Council swiftly launched an investigation into the sudden rise in botulism-like symptoms linked to cosmetic procedures. Their findings pointed to a dangerous black-market product called Toxpia — an unlicensed, counterfeit toxin smuggled in from South Korea and fraudulently marketed as Botox. This illegal product had been circulating within the region’s unregulated beauty industry, leading to what authorities described as the largest botulism outbreak in the UK in nearly a century.
On June 13, roughly two weeks after her treatment, Kaylie’s condition rapidly worsened. At home, she suddenly felt profoundly weak, short of breath, and nauseous. While attempting to walk to the bathroom, she collapsed and lost consciousness. Emergency services were called immediately, but by the time paramedics arrived, Kaylie had stopped breathing.
She was rushed to Sunderland Royal Hospital where medical staff worked frantically to revive her. Kaylie was intubated and placed on a ventilator to support her breathing. She was admitted to the intensive care unit (ICU), where she remained on life support for three harrowing days.
During this time, she received the scarce and costly botulism antitoxin, a treatment that halts the progression of the neurotoxin but does not reverse nerve damage already caused. Due to limited supply and triage priorities, Kaylie had initially missed out on the antitoxin, making her recovery even more precarious.
After several days, Kaylie gradually began to breathe on her own. Although the antitoxin prevented further damage, the road to recovery was slow and uncertain. Nearly a month later, she still suffers from debilitating side effects. She experiences persistent double vision so severe that she must cover one eye with a patch. Her right arm remains weak, and she struggles with everyday activities such as cooking, driving, and lifting her children. Doctors cannot guarantee whether her muscle strength and nerve function will ever fully return.
Adding to Kaylie’s distress, the beautician responsible for the treatment was unqualified and uninsured, leaving Kaylie with limited legal recourse or compensation for her ordeal. The provider later issued an apology, blaming a product-wide fault, but Kaylie considers this an empty gesture.
Determined to prevent others from suffering similarly, Kaylie has become vocal about the urgent need for tighter regulation of the cosmetic industry. She warns the public of the dangers posed by unlicensed practitioners and counterfeit products. “People are playing with lives, not just money,” she told reporters tearfully.
Meanwhile, regulatory agencies including the Medicines and Healthcare products Regulatory Agency (MHRA), UKHSA, and local health authorities continue thorough investigations. Hospitals in the North East have been alerted to be vigilant for more suspected cases, and efforts are underway to secure additional antitoxin supplies from national reserves.

Medical experts emphasize that anyone who has recently undergone cosmetic injections and experiences symptoms such as drooping eyelids, blurred or double vision, difficulty swallowing, slurred speech, or muscle weakness should urgently seek medical help by contacting NHS 111 or attending A&E.
The scandal has reignited calls from campaigners like Save Face and members of parliament for the government to introduce mandatory licensing, minimum training requirements, and stricter product traceability for all non-surgical cosmetic procedures. Such reforms aim to protect vulnerable consumers and prevent unregulated and potentially dangerous treatments from continuing unchecked.
For Kaylie Bailey, the experience has been life-changing and terrifying, a stark reminder that safety must never be compromised for price or convenience. “These injections have become normal for many, but I hope my story makes people think twice — about who they trust and what risks they’re willing to take,” she warns.
